Evolus Inc (EOLS)

Evolus (EOLS) Stock Price & Analysis


EOLS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.51 - $11.49
Previous Close$9.14
Average Volume (3M)561.59K
Market Cap
Enterprise Value$575.84M
Total Cash (Recent Filing)$41.70M
Total Debt (Recent Filing)$96.82M
Price to Earnings (P/E)-7.8
Nov 06, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.18
Shares Outstanding56,971,563
10 Day Avg. Volume365,540
30 Day Avg. Volume561,592
Standard Deviation0.27
Financial Highlights & Ratios
Price to Book (P/B)-6.91
Price to Sales (P/S)10.15
Price to Cash Flow (P/CF)-8.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.43
Enterprise Value/Gross Profit6.21
Enterprise Value/Ebitda-11.56
Price Target Upside135.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Evolus Inc’s price range in the past 12 months?
Evolus Inc lowest stock price was $6.51 and its highest was $11.49 in the past 12 months.
    What is Evolus Inc’s market cap?
    Currently, no data Available
    When is Evolus Inc’s upcoming earnings report date?
    Evolus Inc’s upcoming earnings report date is Nov 06, 2023 which is in 34 days.
      How were Evolus Inc’s earnings last quarter?
      Evolus Inc released its earnings results on Aug 02, 2023. The company reported -$0.195 earnings per share for the quarter, beating the consensus estimate of -$0.253 by $0.058.
        Is Evolus Inc overvalued?
        According to Wall Street analysts Evolus Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Evolus Inc pay dividends?
          Evolus Inc does not currently pay dividends.
          What is Evolus Inc’s EPS estimate?
          Evolus Inc’s EPS estimate is -$0.22.
            How many shares outstanding does Evolus Inc have?
            Evolus Inc has 56,971,560 shares outstanding.
              What happened to Evolus Inc’s price movement after its last earnings report?
              Evolus Inc reported an EPS of -$0.195 in its last earnings report, beating expectations of -$0.253. Following the earnings report the stock price went up 2.134%.
                Which hedge fund is a major shareholder of Evolus Inc?
                Among the largest hedge funds holding Evolus Inc’s share is Graham Capital Management, L.P.. It holds Evolus Inc’s shares valued at 193K.


                  Evolus Stock Smart Score

                  The Evolus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Evolus Inc

                  Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November, 2012 and is headquartered in Newport Beach, CA.


                  Top 5 ETFs holding EOLS

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold EOLS. The ETFs are listed according to market value of EOLS within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Fate Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis